Elimination biotransformation metabolic detoxication phase i. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Microsomes, Liver Liver Bile Feces Hepatocytes Microsomes

Organisms13

Cunninghamella Rats, Inbred F344 Rats, Sprague-Dawley Coxiella Gordonia Bacterium Oncorhynchus kisutch Berberidaceae Hepatophyta Dogs Mucorales Ictaluridae Pseudomonas putida Rhodococcus

Diseases4

Psychoses, Alcoholic Neoplasms Nausea Neutropenia

Chemicals and Drugs71

Bithionol Thymol Glutathione Transferase Cytochrome P-450 Enzyme System Cytochrome P-450 CYP1A1 Aflatoxin B1 Aristolochic Acids Adrenochrome Carcinogens Aminopyrine N-Demethylase Benzo(a)pyrene NAD(P)H Dehydrogenase (Quinone)Glutathione Cytochrome P-450 CYP1A2 DNA Adducts Carboxylesterase Glucosinolates Anticarcinogenic Agents Isoenzymes Thiocyanates Carboxylic Ester Hydrolases Isothiocyanates Cytochrome P-450 CYP3A Xenobiotics Pyrazines Ketoconazole Glucuronosyltransferase Aryl Hydrocarbon Hydroxylases Glucuronides Trichloroethanes Antineoplastic Agents Trinitrotoluene Mixed Function Oxygenases Oxygenases Glucuronates Oxidoreductases, N-Demethylating Prodrugs Troleandomycin Environmental Pollutants Hydrocarbons, Halogenated Monoterpenes Cytochrome P-450 CYP2D6 Toluene Cytochrome P-450 CYP2E1 Pharmaceutical Preparations Recombinant Proteins Equol Methoxyflurane Triazines Antineoplastic Agents, Phytogenic Enzyme Inhibitors Nitroglycerin Water Pollutants, Chemical Arylamine N-Acetyltransferase Carbon Radioisotopes Cytochrome P-450 CYP2B1 Fenthion Pyrazolones Norisoprenoids Coumarins Ethylmorphine Benzaldehydes Hydrocarbons, Aromatic Isoflavones Alprazolam Ethyl Ethers Hydrocarbons, Chlorinated Soil Pollutants 7-Alkoxycoumarin O-Dealkylase Ethylmercuric Chloride Eugenol

Analytical, Diagnostic and Therapeutic Techniques and Equipment19

Clinical Trials, Phase I as Topic Chromatography, High Pressure Liquid Maximum Tolerated Dose Administration, Oral Area Under Curve Mass Spectrometry Drug Administration Schedule Drug Evaluation Metabolic Clearance Rate Infusions, Intravenous Gas Chromatography-Mass Spectrometry Magnetic Resonance Spectroscopy Chromatography, Liquid Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Injections, Intravenous Tandem Mass Spectrometry Spectrometry, Mass, Electrospray Ionization Spectrophotometry, Ultraviolet

Psychiatry and Psychology1

Psychoses, Alcoholic

Phenomena and Processes23

Metabolic Detoxication, Drug Biotransformation Metabolic Detoxication, Phase I Metabolic Detoxication, Phase II DNA Adducts Oxidation-Reduction Enzyme Induction Dose-Response Relationship, Drug Dealkylation Hydroxylation Half-Life Maximum Tolerated Dose Kinetics Substrate Specificity Area Under Curve Metabolic Clearance Rate Stereoisomerism Molecular Structure Drug Interactions Tissue Distribution Biological Availability Species Specificity Time Factors

Information Science1

Molecular Sequence Data

Health Care5

Clinical Trials, Phase I as Topic Biodegradation, Environmental Area Under Curve Disease Eradication Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Health Care

Bithionol Thymol Metabolic Detoxication, Drug Biotransformation Metabolic Detoxication, Phase I Metabolic Detoxication, Phase II Glutathione Transferase Clinical Trials, Phase I as Topic Cytochrome P-450 Enzyme System Microsomes, Liver Cytochrome P-450 CYP1A1 Psychoses, Alcoholic Aflatoxin B1 Cunninghamella Chromatography, High Pressure Liquid Liver Aristolochic Acids Adrenochrome Carcinogens Aminopyrine N-Demethylase Benzo(a)pyrene NAD(P)H Dehydrogenase (Quinone)Glutathione Cytochrome P-450 CYP1A2 DNA Adducts Carboxylesterase Glucosinolates Oxidation-Reduction Anticarcinogenic Agents Enzyme Induction Dose-Response Relationship, Drug Dealkylation Isoenzymes Hydroxylation Half-Life Thiocyanates Carboxylic Ester Hydrolases Maximum Tolerated Dose Isothiocyanates Cytochrome P-450 CYP3A Kinetics Xenobiotics Rats, Inbred F344 Pyrazines Ketoconazole Neoplasms Substrate Specificity Biodegradation, Environmental Administration, Oral Area Under Curve Glucuronosyltransferase Mass Spectrometry Drug Administration Schedule Aryl Hydrocarbon Hydroxylases Drug Evaluation Metabolic Clearance Rate Glucuronides Trichloroethanes Rats, Sprague-Dawley Antineoplastic Agents Stereoisomerism Infusions, Intravenous Molecular Structure Gas Chromatography-Mass Spectrometry Trinitrotoluene Mixed Function Oxygenases Bile Molecular Sequence Data Magnetic Resonance Spectroscopy Drug Interactions Oxygenases Disease Eradication Coxiella Gordonia Bacterium Tissue Distribution Biological Availability Glucuronates Oxidoreductases, N-Demethylating Prodrugs Species Specificity Chromatography, Liquid Antineoplastic Combined Chemotherapy Protocols Feces Treatment Outcome Troleandomycin Time Factors Injections, Intravenous Oncorhynchus kisutch Environmental Pollutants Hepatocytes Hydrocarbons, Halogenated Tandem Mass Spectrometry Monoterpenes Cytochrome P-450 CYP2D6 Toluene Cytochrome P-450 CYP2E1 Pharmaceutical Preparations Recombinant Proteins Equol Methoxyflurane

No FAQ available that match "elimination biotransformation metabolic detoxication phase i"